Embla Medical hf. (CPH:EMBLA)

Embla Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	958.3	928.69	854.89	785.68	718.65	718.67
Revenue Growth (YoY)	11.71%	8.63%	8.81%	9.33%	-0.00%	14.16%
Cost of Revenue	364.46	350.13	320.19	300.11	278.9	263.28
Gross Profit	593.84	578.56	534.7	485.57	439.75	455.39
Selling, General & Admin	420.16	408	381.12	359.97	338.59	328.03
Research & Development	48.2	45.86	40.83	38.14	34.02	31.74
Operating Expenses	468.37	453.86	421.95	398.11	372.61	359.76
Operating Income	125.48	124.7	112.75	87.46	67.14	95.62
Interest Expense	-19.14	-19.52	-23.25	-17.96	-11.2	-9.8
Interest & Investment Income	1.52	1.52	1.97	3.45	0.78	0.17
Earnings From Equity Investments	6.27	6.66	3.34	3.4	0.36	0.4
Currency Exchange Gain (Loss)	-3.31	-4.97	-4.44	-0.67	2.61	1.12
Other Non Operating Income (Expenses)	0.42	-0.45	0.19	0.33	-3.51	-0.87
EBT Excluding Unusual Items	111.24	107.94	90.56	76.01	56.17	86.64
Pretax Income	111.24	107.94	90.56	76.01	56.17	86.64
Income Tax Expense	25.11	24.29	21.6	17.21	12.96	20.98
Earnings From Continuing Operations	86.12	83.65	68.96	58.8	43.21	65.66
Minority Interest in Earnings	-0.49	-0.31	-0.68	-0.41	-0.7	-1.66
Net Income	85.63	83.34	68.28	58.39	42.51	63.99
Net Income to Common	85.63	83.34	68.28	58.39	42.51	63.99
Net Income Growth	18.64%	22.05%	16.94%	37.34%	-33.57%	929.84%
Shares Outstanding (Basic)	425	427	427	420	418	422
Shares Outstanding (Diluted)	425	427	427	420	418	423
Shares Change (YoY)	-0.42%	0.08%	1.51%	0.60%	-1.17%	0.02%
EPS (Basic)	0.20	0.20	0.16	0.14	0.10	0.15
EPS (Diluted)	0.20	0.20	0.16	0.14	0.10	0.15
EPS Growth	19.15%	21.96%	15.20%	36.53%	-32.78%	929.72%
Free Cash Flow	106.78	110.55	89.03	65.09	44.22	83.57
Free Cash Flow Per Share	0.25	0.26	0.21	0.15	0.11	0.20
Gross Margin	61.97%	62.30%	62.55%	61.80%	61.19%	63.37%
Operating Margin	13.09%	13.43%	13.19%	11.13%	9.34%	13.31%
Profit Margin	8.94%	8.97%	7.99%	7.43%	5.92%	8.91%
Free Cash Flow Margin	11.14%	11.90%	10.42%	8.29%	6.15%	11.63%
EBITDA	152.53	150.14	136.92	108.29	89.45	119.86
EBITDA Margin	15.92%	16.17%	16.02%	13.78%	12.45%	16.68%
D&A For EBITDA	27.06	25.45	24.16	20.83	22.31	24.23
EBIT	125.48	124.7	112.75	87.46	67.14	95.62
EBIT Margin	13.09%	13.43%	13.19%	11.13%	9.34%	13.31%
Effective Tax Rate	22.58%	22.50%	23.85%	22.64%	23.08%	24.22%

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.